Icagen
is a biotechnology firm that focuses on researching and developing drugs for the treatment of infectious diseases... Read moreIcagen
is a biotechnology firm that focuses on researching and developing drugs for the treatment of infectious diseases... Read more
News
Dec 22, 2021
FirstWord PHARMA
Icagen: Ligand and GSK Expand Global Collaboration and License Agreement
Dec 21, 2020
Business Wire
Press Release: Icagen : Ligand and GSK Enter Global Collaboration and License Agreement Leveraging Icagen's Discovery Technology to Target Neurological Disorders
Jun 02, 2020
The Business Journals: Greensboro/Winston-Salem/High Point
Icagen: Durham firm lands potential $274 million deal with pharma giant
Jun 01, 2020
WRAL TechWire
Icagen: Raleigh-based Icagen lands potential $274M+ development deal with Roche
Apr 07, 2020
socalTECH
Icagen: Ligand Buys Assets From Icagen
Apr 02, 2020
BioSpace
Icagen: Ligand Completes Acquisition of Icagen Core Assets, Partnered Programs and Ion Channel Technologies
Feb 12, 2020
FierceBiotechIT
Icagen: Ligand snags Roche-partnered drug in Icagen buyout
Feb 12, 2020
BioPortfolio
Icagen: Ligands Icagen Deal Brings Neuro CF Assets Plus Partnering Potential
Feb 12, 2020
Pharmaceutical Business Review
Icagen: Ligand agrees to acquire core assets, partnered programmes and ion channel technologies from Icagen
Jan 30, 2020
BioPortfolio
Icagen: Icagen Inc Strategic SWOT Analysis Review Published by Global Data Prices from USD $106
Icagen Competitors
1
2
3
4
5
6
7
8
9
10